Table 2.
Possible molecules and their role in acute myeloid leukemia stem cells-bone marrow microenvironment interaction
| Target | Source | Role | Ref. |
| VLA-4 | AML LSCs | Homing | [37] |
| CD44 | AML LSCs | Homing | [38,96] |
| CXCR4 | AML LSCs | Adhesion | [40] |
| Jagged-1 | Osteoblast | Proliferation | [42] |
| CXCR2 | AML LSCs | Proliferation, survival | [44] |
| Parathyroid hormone | BMM | OB proliferation, LSCs growth | [97] |
| Proangiogenesis factors (VEGF, HGF, BFGF, VEGFR) | AML LSCs, BMM | Endothelial and LSC proliferation | [47,48] |
| Cytokines (IL-6, IL1β, TNFα, G-CSF, GM-CSF) | AML LSCs, BMM | Angiogenesis, LSC proliferation | [51] |
| Tie-2 | Osteoblast | LSCs quiescent | [46] |
| CD36 | AML LSCs | Energy source provider | [56] |
AML LSC: Acute myeloid leukemia stem cell; BMM: Bone marrow microenvironment; VLA-4: Very late antigen-4; CXCR4: C-X-C chemokine receptor type 4; CXCR2: C-X-C chemokine receptor type 2; VEGF: Vascular endothelial growth factor; HGF: Hepatocyte growth factor; BFGF: Basic fibroblast growth factor; VEGFR: Vascular endothelial growth factor receptor; IL-6: Interleukin-6; IL-1β: Interleukin-1 beta, TNFα: Tumor necrosis factor alpha; G-CSF: Granulocyte-colony stimulating factor; GM-CSF: Granulocyte-monocyte colony stimulating factor.